Be Biopharma
MA - CambridgePharmaceutical
Focus: Be Biopharma is an early-stage biotech focused on engineered B cell therapeutics for rare diseases, founded in 2023 and based in Cambridge, MA. The company is in pre-clinical to early clinical stages with a single Phase 1/2 program.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Be Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Be Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BE-101
Hemophilia BClinical Trials (1)
NCT06611436BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B
Phase 1/2Help build intelligence for Be Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.